Agios Pharmaceuticals
AGIO
AGIO
151 hedge funds and large institutions have $2.64B invested in Agios Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 63 increasing their positions, 39 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
21% less call options, than puts
Call options by funds: $19.4M | Put options by funds: $24.4M
Holders
151
Holding in Top 10
5
Calls
$19.4M
Puts
$24.4M
Top Buyers
1 | +$116M | |
2 | +$52.1M | |
3 | +$32.5M | |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$27.9M |
5 |
Capital International Investors
Los Angeles,
California
|
+$19.6M |
Top Sellers
1 | -$344M | |
2 | -$13.7M | |
3 | -$13.7M | |
4 |
UBS Group
Zurich,
Switzerland
|
-$13.4M |
5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$8.68M |